These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 31863004)

  • 41. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
    Yi J; Shi X; Xuan Z; Wu J
    Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models.
    Daggubati V; Hochstelter J; Bommireddy A; Choudhury A; Krup AL; Kaur P; Tong P; Li A; Xu L; Reiter JF; Raleigh DR
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33476305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
    Niesen J; Ohli J; Sedlacik J; Dührsen L; Hellwig M; Spohn M; Holsten T; Schüller U
    Cancer Lett; 2020 May; 477():10-18. PubMed ID: 32112900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
    Hallahan AR; Pritchard JI; Hansen S; Benson M; Stoeck J; Hatton BA; Russell TL; Ellenbogen RG; Bernstein ID; Beachy PA; Olson JM
    Cancer Res; 2004 Nov; 64(21):7794-800. PubMed ID: 15520185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
    Hatton BA; Knoepfler PS; Kenney AM; Rowitch DH; de Alborán IM; Olson JM; Eisenman RN
    Cancer Res; 2006 Sep; 66(17):8655-61. PubMed ID: 16951180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.
    Dijkgraaf GJ; Alicke B; Weinmann L; Januario T; West K; Modrusan Z; Burdick D; Goldsmith R; Robarge K; Sutherlin D; Scales SJ; Gould SE; Yauch RL; de Sauvage FJ
    Cancer Res; 2011 Jan; 71(2):435-44. PubMed ID: 21123452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors.
    Parathath SR; Mainwaring LA; Fernandez-L A; Campbell DO; Kenney AM
    Development; 2008 Oct; 135(19):3291-300. PubMed ID: 18755774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.
    Wu CC; Hou S; Orr BA; Kuo BR; Youn YH; Ong T; Roth F; Eberhart CG; Robinson GW; Solecki DJ; Taketo MM; Gilbertson RJ; Roussel MF; Han YG
    Dev Cell; 2017 Dec; 43(6):673-688.e5. PubMed ID: 29103956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sox2 requirement in sonic hedgehog-associated medulloblastoma.
    Ahlfeld J; Favaro R; Pagella P; Kretzschmar HA; Nicolis S; Schüller U
    Cancer Res; 2013 Jun; 73(12):3796-807. PubMed ID: 23596255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation.
    Wong H; Alicke B; West KA; Pacheco P; La H; Januario T; Yauch RL; de Sauvage FJ; Gould SE
    Clin Cancer Res; 2011 Jul; 17(14):4682-92. PubMed ID: 21610148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stem-Like Cell Populations, p53-Pathway Activation and Mechanisms of Recurrence in Sonic Hedgehog Medulloblastoma.
    Treisman D; Li Y; Zhu Y
    Neuromolecular Med; 2022 Mar; 24(1):13-17. PubMed ID: 34165693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.
    Susanto E; Marin Navarro A; Zhou L; Sundström A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Hübner JM; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjö P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20127-20138. PubMed ID: 32747535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists.
    Metcalfe C; de Sauvage FJ
    Cancer Res; 2011 Aug; 71(15):5057-61. PubMed ID: 21771911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of Sonic hedgehog during cell proliferation in the human cerebellum.
    Haldipur P; Bharti U; Govindan S; Sarkar C; Iyengar S; Gressens P; Mani S
    Stem Cells Dev; 2012 May; 21(7):1059-68. PubMed ID: 21732818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted treatment for sonic hedgehog-dependent medulloblastoma.
    Kieran MW
    Neuro Oncol; 2014 Aug; 16(8):1037-47. PubMed ID: 24951114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.
    Fernandez-L A; Northcott PA; Dalton J; Fraga C; Ellison D; Angers S; Taylor MD; Kenney AM
    Genes Dev; 2009 Dec; 23(23):2729-41. PubMed ID: 19952108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
    Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
    Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases.
    Climans SA; Macdonald DR; Sutherland DE; Mason WP
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Conduit SE; Ramaswamy V; Remke M; Watkins DN; Wainwright BJ; Taylor MD; Mitchell CA; Dyson JM
    Oncogene; 2017 Oct; 36(43):5969-5984. PubMed ID: 28650469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.